Get the Stockscreener App
71.35
1.00%
-0.72
After Hours:
71.35
Edwards Lifesciences Corp Stock (EW) Forecast
The Edwards Lifesciences Corp (EW) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $102.86, representing a +44.16% increase from the current price of $71.35. The highest analyst price target is $105.12, and the lowest is $100.60.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month EW Price Target
Average 95.86
(+34.35% Upside)
Is Edwards Lifesciences Corp (EW) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 62.07 | Neutral |
| STOCH(9,6) | 88.54 | Sell |
| STOCHRSI(14) | 81.37 | Sell |
| MACD(12,26) | 1.0053 | Buy |
| ADX(14) | 19.29 | Neutral |
| William %R | -16.54 | Sell |
| CCI(14) | 63.79 | Neutral |
Buy: 1
Sell: 3
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
70.45
Buy
|
70.39
Buy
|
| MA20 |
68.41
Buy
|
69.41
Buy
|
| MA50 |
68.00
Buy
|
69.02
Buy
|
| MA100 |
69.41
Buy
|
71.22
Buy
|
| MA200 |
79.34
Sell
|
73.84
Sell
|
Buy: 8
Sell: 2
Neutral: 0
Summary: Buy
According to our latest analysis, EW could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 5 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on EW, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 62.07 indicates that EW is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 88.54 indicates that EW is oversold. This means that EW price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 81.37 indicates that EW is oversold. This suggests that EW price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 19.29 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 63.79 indicates that EW is still overbought but not to an extreme extent.
Long-term EW price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Edwards Lifesciences Corp financial reports and earnings history, Edwards Lifesciences Corp (EW) stock could reach $110.82 by 2030, $184.09 by 2040 and $261.11 by 2050. See the projected annual prices until 2050 of the Edwards Lifesciences Corp stock below:
- Edwards Lifesciences Corp (EW) is expected to reach an average price of $133.63 in 2035, with a high prediction of $133.71 and a low estimate of $126.03. This indicates an $87.28% rise from the last recorded price of $71.35.
- Edwards Lifesciences Corp (EW) stock is projected to chart a bullish course in 2040, with an average price target of $183.22, representing an $156.79% surge from its current level. The forecast ranges from a conservative $176.58 to a sky-high $184.09.
- Our analysts predict Edwards Lifesciences Corp (EW) to jump 189.94% by 2045, soaring from $204.38 to an average price of $206.87, potentially reaching $220.60. While $204.38 is the low estimate, the potential upside is significant.
- Edwards Lifesciences Corp (EW) stock is expected to climb by 2050, reaching an average of $260.65, a $265.31% jump from its current level. However, a wide range of estimates exists, with high and low targets of $261.11 and $248.85, respectively, highlighting the market's uncertainty.
Edwards Lifesciences Corp Stock (EW) Year by Year Forecast
Edwards Lifesciences Corp Stock (EW) Price Forecast for 2025
Edwards Lifesciences Corp Stock (EW) is expected to reach an average price of $95.86 in 2025, with a high prediction of $114.44 and a low estimate of $77.28. This indicates an +34.35% rise from the last recorded price of $71.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $102.61 | $100.60 | $105.12 | +43.81% |
| February, 2025 | $98.67 | $97.22 | $107.37 | +38.29% |
| March, 2025 | $92.07 | $92.01 | $104.70 | +29.04% |
| April, 2025 | $89.48 | $77.28 | $98.64 | +25.40% |
| May, 2025 | $101.06 | $82.27 | $102.04 | +41.64% |
| June, 2025 | $97.01 | $94.20 | $101.36 | +35.97% |
| July, 2025 | $96.38 | $92.52 | $103.54 | +35.08% |
| August, 2025 | $94.20 | $92.75 | $98.09 | +32.03% |
| September, 2025 | $103.43 | $93.34 | $106.92 | +44.96% |
| October, 2025 | $110.35 | $102.01 | $114.44 | +54.66% |
| November, 2025 | $106.53 | $100.81 | $112.39 | +49.31% |
| December, 2025 | $98.64 | $97.87 | $113.86 | +38.24% |
Edwards Lifesciences Corp Stock (EW) Price Forecast for 2026
The predicted value for Edwards Lifesciences Corp (EW) in 2026 is set at an average of $125.47. Estimates vary from a peak of $151.82 to a trough of $99.12, indicating an +75.85% surge from the present price of $71.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $112.34 | $99.12 | $115.04 | +57.45% |
| February, 2026 | $114.00 | $110.23 | $114.95 | +59.77% |
| March, 2026 | $115.21 | $110.46 | $119.35 | +61.47% |
| April, 2026 | $111.81 | $109.29 | $116.80 | +56.71% |
| May, 2026 | $107.04 | $106.08 | $114.45 | +50.02% |
| June, 2026 | $113.68 | $106.47 | $114.32 | +59.32% |
| July, 2026 | $117.42 | $113.19 | $125.94 | +64.57% |
| August, 2026 | $128.05 | $116.92 | $128.16 | +79.47% |
| September, 2026 | $135.74 | $127.63 | $137.24 | +90.24% |
| October, 2026 | $143.58 | $130.99 | $143.95 | +101.23% |
| November, 2026 | $145.67 | $139.21 | $148.40 | +104.16% |
| December, 2026 | $141.84 | $141.62 | $151.82 | +98.79% |
Edwards Lifesciences Corp Stock (EW) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Edwards Lifesciences Corp (EW) is $138.26, with a high forecast of $160.88 and a low forecast of $115.65. This indicates an +93.78% increase from the last price of $71.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $145.36 | $134.38 | $145.76 | +103.72% |
| February, 2027 | $145.95 | $138.82 | $149.68 | +104.55% |
| March, 2027 | $151.20 | $136.10 | $152.64 | +111.92% |
| April, 2027 | $147.47 | $145.91 | $160.88 | +106.69% |
| May, 2027 | $141.53 | $125.67 | $148.81 | +98.35% |
| June, 2027 | $140.15 | $132.01 | $143.50 | +96.43% |
| July, 2027 | $147.36 | $130.55 | $150.07 | +106.53% |
| August, 2027 | $148.15 | $146.86 | $160.87 | +107.64% |
| September, 2027 | $131.06 | $121.39 | $149.71 | +83.68% |
| October, 2027 | $117.86 | $115.65 | $131.66 | +65.18% |
| November, 2027 | $128.59 | $118.62 | $129.32 | +80.22% |
| December, 2027 | $135.16 | $124.04 | $138.22 | +89.44% |
Edwards Lifesciences Corp Stock (EW) Price Forecast for 2028
In 2028, Edwards Lifesciences Corp (EW) is projected to reach an average price of $116.92, with a high projection of $135.85 and a low estimate of $97.99. This indicates an +63.87% rise from the last price of $71.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $119.19 | $118.44 | $135.85 | +67.04% |
| February, 2028 | $113.26 | $112.50 | $128.91 | +58.74% |
| March, 2028 | $103.22 | $100.46 | $119.93 | +44.67% |
| April, 2028 | $107.28 | $97.99 | $107.70 | +50.36% |
| May, 2028 | $105.28 | $102.04 | $109.53 | +47.55% |
| June, 2028 | $110.51 | $103.73 | $110.67 | +54.88% |
| July, 2028 | $108.55 | $106.25 | $116.17 | +52.14% |
| August, 2028 | $105.86 | $105.56 | $113.64 | +48.36% |
| September, 2028 | $115.53 | $105.09 | $115.57 | +61.92% |
| October, 2028 | $120.52 | $113.46 | $121.04 | +68.91% |
| November, 2028 | $117.28 | $112.82 | $121.56 | +64.38% |
| December, 2028 | $126.40 | $114.67 | $126.94 | +77.16% |
Edwards Lifesciences Corp Stock (EW) Price Forecast for 2029
The 2029 price forecast for Edwards Lifesciences Corp Stock (EW) is $111.49 on average, with a high prediction of $129.67 and a low estimate of $93.30. This represents an +56.25% increase from the previous price of $71.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $114.31 | $114.06 | $126.48 | +60.21% |
| February, 2029 | $108.54 | $107.27 | $114.37 | +52.12% |
| March, 2029 | $105.70 | $105.26 | $111.02 | +48.15% |
| April, 2029 | $103.41 | $100.99 | $106.97 | +44.94% |
| May, 2029 | $97.01 | $93.30 | $105.96 | +35.96% |
| June, 2029 | $101.29 | $96.90 | $101.52 | +41.96% |
| July, 2029 | $109.31 | $99.82 | $112.04 | +53.20% |
| August, 2029 | $111.70 | $104.76 | $113.16 | +56.55% |
| September, 2029 | $121.10 | $110.37 | $123.49 | +69.72% |
| October, 2029 | $127.31 | $117.03 | $128.76 | +78.43% |
| November, 2029 | $119.59 | $119.03 | $129.67 | +67.61% |
| December, 2029 | $108.42 | $106.51 | $122.86 | +51.95% |
Edwards Lifesciences Corp Stock (EW) Price Forecast for 2030
Edwards Lifesciences Corp Stock (EW) is expected to reach an average price of $117.96 in 2030, with a high forecast of $132.88 and a low forecast of $103.04. This signifies an +65.33% surge from the last price of $71.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $109.75 | $103.66 | $110.82 | +53.82% |
| February, 2030 | $112.51 | $109.46 | $113.85 | +57.68% |
| March, 2030 | $120.51 | $111.28 | $122.20 | +68.91% |
| April, 2030 | $123.02 | $118.28 | $124.76 | +72.42% |
| May, 2030 | $123.10 | $118.87 | $125.55 | +72.52% |
| June, 2030 | $125.93 | $120.96 | $129.40 | +76.50% |
| July, 2030 | $130.50 | $125.89 | $132.82 | +82.90% |
| August, 2030 | $129.33 | $125.84 | $132.88 | +81.27% |
| September, 2030 | $128.40 | $126.84 | $130.10 | +79.95% |
| October, 2030 | $127.94 | $122.72 | $132.84 | +79.31% |
| November, 2030 | $111.56 | $109.17 | $130.30 | +56.36% |
| December, 2030 | $113.92 | $103.04 | $119.09 | +59.67% |
0.27%
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):